These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2996747)

  • 1. Increased survival with high-dose multifield radiotherapy and intensive chemotherapy in limited small cell carcinoma of the lung.
    Shank B; Scher H; Hilaris BS; Pinsky C; Martin M; Wittes RE
    Cancer; 1985 Dec; 56(12):2771-8. PubMed ID: 2996747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
    Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
    Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer.
    Scher HI; Shank B; Chapman R; Geller N; Pinsky C; Gralla R; Kelsen D; Bosl G; Golbey R; Petroni G
    Cancer Res; 1988 Mar; 48(6):1663-70. PubMed ID: 2830968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
    Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
    J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
    Payne DG; Murray N; Warde P
    Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.
    Maurer LH; Pajak T; Eaton W; Comis R; Chahinian P; Faulkner C; Silberfarb PM; Henderson E; Rege VB; Baldwin PE
    J Clin Oncol; 1985 Jul; 3(7):969-76. PubMed ID: 2991478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of small cell lung cancer. Two-drug versus four-drug chemotherapy and loco-regional irradiation with or without prophylactic cranial irradiation.
    Niiranen A; Holsti P; Salmo M
    Acta Oncol; 1989; 28(4):501-5. PubMed ID: 2551355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients.
    Le Chevalier T; Arriagada R; de Thé H; De Cremoux H; Martin M; Baldeyrou P; Ruffié P; Benna F; Cerrina ML; Sancho-Garnier H
    NCI Monogr; 1988; (6):335-8. PubMed ID: 2832769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined methotrexate and high-dose vincristine chemotherapy with radiation therapy for small cell bronchogenic carcinoma.
    Holoye PY; Libnoch JA; Anderson T; Cox JD; Byhardt RW; Hoffmann RG
    Cancer; 1985 Apr; 55(7):1436-45. PubMed ID: 2983855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy and radiation therapy for small cell carcinoma of the lung].
    Hara N; Ichinose Y; Motohiro A; Noge S; Miyake J; Ohta M; Hata K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):80-5. PubMed ID: 3002286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Small-cell lung cancer].
    Perevodchikova NI
    Vopr Onkol; 1989; 35(2):151-4. PubMed ID: 2538957
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
    Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
    J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.
    Work E; Nielsen OS; Bentzen SM; Fode K; Palshof T
    J Clin Oncol; 1997 Sep; 15(9):3030-7. PubMed ID: 9294465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined chemotherapeutic and radiotherapeutic treatment of limited pulmonary microcytoma].
    Latini P; Maranzano E; Checcaglini F; Tonato M; Crinò L; Panizza BM; Aristei C
    Radiol Med; 1987 Jun; 73(6):539-44. PubMed ID: 3037623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
    Kies MS; Mira JG; Crowley JJ; Chen TT; Pazdur R; Grozea PN; Rivkin SE; Coltman CA; Ward JH; Livingston RB
    J Clin Oncol; 1987 Apr; 5(4):592-600. PubMed ID: 3031226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
    Humblet Y; Symann M; Bosly A; Delaunois L; Francis C; Machiels J; Beauduin M; Doyen C; Weynants P; Longueville J
    J Clin Oncol; 1987 Dec; 5(12):1864-73. PubMed ID: 2824708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer.
    Yamada K; Saijo N; Kojima A; Ohe Y; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Goya T; Kondou H
    Jpn J Clin Oncol; 1991 Feb; 21(1):39-45. PubMed ID: 1648633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.